We are smashing the traditional healthcare silos at MedCity CONVERGE. MedCityNews.com’s summit on innovation and healthcare convergence July 10 in Philadelphia will gather the entire medical innovation ecosystem:
- from medtech to pharma to digital health
- from investor to entrepreneur
- from innovation-minded practitioners and hospital leaders to thoughtful and forward-thinking payers
They’ll all be shoulder to shoulder talking about what’s next, and if you join us, you’ll leave this one-day, executive-level conference with tangible opportunities and ideas you can act on right away.
1. How will I get paid for data-driven innovation?
Incentives in the healthcare system are shifting to reward improvements in quality, health, and value, and key information to power these improvements is being liberated at multiple levels. At the same time, for the first time in human history, the customer has access to more healthcare information than ever before (even as companies also have more data about consumers than ever before).
Wil Yu, from the U.S. Health and Human Services, and Brandon Rowberry, vice president of innovation at UnitedHealth Group, will be among those offering a point of view on how the government and insurance companies look at data, and how they are supporting, enabling and engaged in innovation.
2. What standards will healthcare app developers be held to in the future?
There’s unfettered enthusiasm about digital health. But there’s an increasing amount of “m-skepticism,” too. Just how – and when – does a mobile platform contribute to the health of the person using the app? And what kind of clinically backed standards should digital entrepreneurs expect to be held to in the future? Entrepreneurs will talk about what they’ve encountered with their apps, how they’re holding themselves accountable, and hospital executives and leaders from Robert Wood Johnson Foundation will outline the beginning of an mHealth accountability framework.
3. What convergence is actually worth investing in?
Entrepreneurs can receive an investment from more diverse sources than ever: venture capitalists, new corporate funds, health systems and even the public sector and grant makers who are eager to get a piece of the next innovation. But amid the choices within personalized medicine, telehealth, mobile apps, big data, electronic medical record solutions and other segments, what opportunities will catch an investor’s eye and which sectors are seen as more hype than promise?
4. How can research institutions do a better job bringing their innovations to market?
Great ideas developed in hospitals and universities aren’t coming out fast enough. But, on the bright side, more researchers and industry leaders are finding a way to do it right. Is it a matter of more innovation-minded doctors and researchers? Or does the way a university negotiates and supports its commercializable technologies have to change? A whiteboard session with researcher leaders will pick apart the good and the bad of tech transfer. By session’s end, there will be action items to help develop a better way to bring innovations from bench to bedside.
5. What does innovation mean for the new medical device sector? And what does that sector look like now?
Could there really be an app for every medical device? And will the medical device sector – post healthcare reform and completely globalized – even be interested? The medtech sector will be transformed by decisions in Washington, D.C., as well as its own global aspirations. Find out what medtech executives are thinking about the opportunities to innovate – in data, in healthcare delivery and beyond – and how they’ll work with other entrepreneurs in the future.
Curious? Want to be a part of the conversation with people who will influence the healthcare innovation ecosystem? Buy a ticket today for MedCity CONVERGE, our summit on innovation and healthcare convergence July 10 in Philadelphia.